Reference health
Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
23/23 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 23 checked references that resolve
resolves10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
resolves10.1007/s10198-021-01338-5
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies
resolves10.1093/eurpub/cku088
Breast cancer diagnosis and death in the Netherlands: a changing burden
resolves10.1186/s12885-018-4158-3
Burden of early, advanced and metastatic breast cancer in The Netherlands
resolves10.1002/ijc.29364
The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy
resolves10.1056/NEJMoa050518
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
resolves10.1371/journal.pone.0030157
Contribution of Early Detection and Adjuvant Treatments to Breast Cancer Mortality Reduction in Catalonia, Spain
resolves10.1016/j.healthpol.2018.08.004
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST)
resolves10.1016/j.ejca.2008.09.015
Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland
resolves10.1002/ijc.33126
Risk stratification in breast cancer screening: Cost‐effectiveness and harm‐benefit ratios for low‐risk and high‐risk women
resolves10.1093/jnci/djab119
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue
resolves10.1016/S1470-2045(20)30398-3
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
resolves10.1258/jms.2012.012083
False-Positive Results in Mammographic Screening for Breast Cancer in Europe: A Literature Review and Survey of Service Screening Programmes
resolves10.1148/radiol.2020192505
Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis
resolves10.1111/j.1524-4733.2007.00223.x
Probabilistic Cost-Effectiveness Modeling of Different Breast Cancer Screening Policies in Slovenia
resolves10.1056/NEJMp1405158
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
resolves10.1186/1471-2407-11-192
Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)
resolves10.1016/j.jval.2015.09.2939
Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
resolves10.1371/journal.pone.0086858
Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
resolves10.1038/s41416-021-01261-9
Effects of cancer screening restart strategies after COVID-19 disruption
The 10 references without a DOI — listed, not checked
no DOI — not checkedBreast Cancer Screening
no DOI — not checkedCancer screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening
no DOI — not checkedRIVM.Center for population screening. Arbeidsmarktproblematiek in het bevolkingsonderzoek borstkanker; verlate uitnodigingen;2019.
no DOI — not checkedMammography screening in Italy: 2008 survey
no DOI — not checkedLevensverwachting; Geslacht, Leeftijd (Per Jaar en Periode Van Vijf Jaren)
no DOI — not checkedGuide to the Methods of Technology Appraisal 2013 Process and Methods
no DOI — not checkedCost‐effectiveness in practice
no DOI — not checkedProsnoge Bevolking; Geslacht en leeftijd
no DOI — not checkedWorld Cancer Report: Cancer Research for Cancer preventioned
no DOI — not checkedScreening Ages and Frequencies
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/ijc.34000"><img src="https://citestamp.com/citestamped/10.1002/ijc.34000/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/ijc.34000)